Skip to content
Get started

GILD

Gilead Sciences, Inc.

  • sector: Healthcare
  • in 2 Arithmos indices

Indices that include GILD 2/2

sort
weight≥ 0.0%
alongside
  1. #1

    Recession-Resilient US Defensive 20 — Equal-Weighted

    GILD · 5.00%JNJABBVUNHMRK+15 more

    Biopharmaceutical leader in HIV, hepatitis, and oncology; 79% gross margin and 41% ROE with moderate P/E (19.7) indicate consistent FCF profile. Equal-weighted per user specification.

    CAGR
    9.5%
    Sharpe
    0.61
    max DD
    -26.1%
  2. #2

    Recession-Resilient US Defensive 20 — Equal-Weighted

    GILD · 5.00%PGKOPEPCL+15 more

    Biopharmaceutical company with $165B market cap and 79% gross margin. Equal-weighted at 5%; HIV and oncology franchises provide predictable cash generation.

    CAGR
    7.4%
    Sharpe
    0.46
    max DD
    -28.6%

Build your own index that includes GILD.

Write a plain-English prompt, get transparent rules and a 10-year backtest.

start a prompt →

Performance figures are simulated backtests, not live returns. Past performance does not predict future results. Arithmos is a research and data tool, not investment advice.

A research tool, not investment advice. Past performance doesn't guarantee future results. Learn more